Exelixis
EXEL
#1759
Rank
S$15.52 B
Marketcap
S$59.77
Share price
2.09%
Change (1 day)
24.49%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company